A 1000mg dosage strength of Glumetza (metformin hydrochloride extended-release tablets, from Depomed) has been approved by the FDA in addition to the 500mg strength already on the market. Glumetza is indicated as monotherapy, or in combination with a sulfonylurea or insulin, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

For more information call 1-866-GLUMETZA or visit www.glumetzaxr.com.